VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SONMDNA X, Inc.
$5.70$72M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSONMCash Flow

DNA X, Inc. (SONM) Cash Flow Statement

9Y historyFree accessUpdated daily

The company continues to burn cash, evidenced by a negative $9.6 million in operating cash flow during 2025Q1, despite reporting a nominal net income of $458,000 in the same period.

SONM Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Cash from Operations-17.39M-23.53M-8.49M-4.05M-12.36M-38.48M-10.56M-33.52M3.86M-8.91M
Operating CF Margin %---14.56%-4.33%-17.7%-70.51%-16.5%-28.84%2.85%-15.09%
Operating CF Growth %-1511.26%-177.23%-109.43%67.22%67.88%-264.36%68.5%-968.25%143.35%-
Net Income-14.78M-20.66M-33.65M-90K-14.09M-38.63M-29.93M-25.83M1.28M-8.52M
Depreciation & Amortization-1.05M4.3M3.54M2.21M2.38M2.13M2.73M3.52M1.85M1.32M
Stock-Based Compensation14K1.54M1.52M1.5M1.55M1.08M1.09M6.31M252K104K
Deferred Taxes00000-35K21K109K140K-284K
Other Non-Cash Items-28.45M-3.62M9.79M644K-869K2.27M1.5M3.25M1.47M928K
Working Capital Changes6.22M-5.09M10.3M-8.31M-1.33M-5.3M14.04M-20.88M-1.13M-2.45M
Change in Receivables-13.28M-19.5M-6.11M-1.72M-11.63M-7.52M5.46M8.75M-8.06M-3.67M
Change in Inventory7.08M3.85M-4.99M-2.61M1.63M4.18M7.49M-809K-12.85M3.37M
Change in Payables12.43M9.53M14.31M-1.28M11.65M617K1.49M-20.07M16.05M-3.35M
Cash from Investing3.36M0-214K-36K-8K-46K-11K-1.36M-2.54M-999K
Capital Expenditures00-214K-36K-8K-46K-11K-1.36M-2.54M-1.17M
CapEx % of Revenue0%-0.37%0.04%0.01%0.08%0.02%1.17%1.88%1.99%
Acquisitions3.36M000000000
Investments----------
Other Investing0000000000
Cash from Financing13.11M19.49M4.65M272K14.35M27.61M21.41M33.13M10.15M4.42M
Debt Issued (Net)8.08M5.82M591K-147K-67K-148K-4.15M-3.69M1.86M4.59M
Equity Issued (Net)5.02M13.67M4.01M419K14.41M27.7M25.57M38.47M8.29M0
Dividends Paid0000000000
Share Repurchases0000000000
Other Financing0048K0060K-6K-1.65M-5K-170K
Net Change in Cash-920K-4.04M-4.05M-3.82M1.98M-10.91M10.84M-1.75M11.47M-5.49M
Free Cash Flow-17.39M-23.53M-8.7M-4.09M-12.37M-38.52M-10.57M-34.88M1.32M-10.08M
FCF Margin %103.98%--14.92%-4.37%-17.71%-70.59%-16.52%-30%0.97%-17.08%
FCF Growth %3.99%-170.41%-112.82%66.95%67.89%-264.41%69.69%-2750.38%113.06%-
FCF per Share-1.37-1.81-1.84-0.95-4.28-40.70-22.88-187.4938.17-981.88
FCF Conversion (FCF/Net Income)1.18x1.14x0.25x45.02x0.88x1.00x0.35x1.30x3.02x1.05x
Interest Paid221K945K29K15K97K0260K1.04M546K306K
Taxes Paid16K122K134K42K151K87K76K273K259K198K

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Imminent liquidity and solvency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Persistent Disconnect Between Earnings Reality

As reported in financial statements, Sonim's operating cash flow consistently trails net income, with the company recording a negative $9.6 million in operating cash flow during 2025Q1 despite a positive net income of $458,000, highlighting a severe lack of quality in reported earnings.

The persistent divergence between net income and operating cash flow suggests that accounting profits are not translating into actual liquidity. This gap implies that non-cash items or aggressive accrual accounting may be masking the underlying cash burn, warranting extreme caution from investors.

Free Cash Flow Trajectory Remains Negative

Based on recent SEC filings, Sonim's free cash flow has remained deeply negative across the observed ten-quarter period, reaching a low of negative $9.6 million in 2025Q1, which underscores the company's inability to generate self-sustaining cash flow from its current business model.

The consistent failure to achieve positive free cash flow suggests that the company's operational model is fundamentally incapable of covering its own expenses. This trajectory indicates that the business remains entirely dependent on external financing to survive, which is increasingly difficult given the current liquidity constraints.

Working Capital Volatility Signals Instability

According to the provided cash flow data, working capital changes have been highly erratic, swinging from a $10.6 million inflow in 2024Q4 to a $6.1 million outflow in 2025Q1, reflecting significant instability in the company's ability to manage its operational cycles effectively.

Such extreme fluctuations in working capital suggest that the company is struggling to manage its inventory and accounts receivable effectively. This volatility may indicate that the company is forced to rely on aggressive payment terms or inventory liquidations to manage its immediate cash needs.

Capital Deployment Limited by Liquidity

As evidenced by the historical cash flow statements, Sonim has been unable to engage in meaningful capital deployment, with zero dividends or share repurchases reported, while the company instead utilized $3.4 million for acquisitions in 2026Q1 despite a precarious cash position of only $1.3 million.

The decision to pursue acquisitions while facing a severe liquidity crisis appears highly questionable and warrants further investigation into management's capital allocation priorities. This strategy may indicate a desperate attempt to pivot the business model at the expense of maintaining a necessary cash buffer.

SONM — Frequently Asked Questions

Quick answers to the most common questions about buying SONM stock.

How much cash does DNA X, Inc. (SONM) generate from operations?

DNA X, Inc. (SONM) generated $-23.5M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is DNA X, Inc.'s free cash flow?

DNA X, Inc. (SONM) reported negative free cash flow of $23.5M in 2025, indicating capital requirements exceeded cash from operations.

What is DNA X, Inc.'s capital expenditure (CapEx)?

DNA X, Inc. (SONM) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.